/Johnson%20%26%20Johnson%20corporate%20building%20By%20PixelBiss.jpeg){kind=tracking}
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. The company has a market cap of $616.5 billion and operates in two segments, Innovative Medicine and MedTech.
Shares of Johnson & Johnson have outperformed the broader market over the past year, surging 54.1% compared to the S&P 500 Index’s ($SPX) 16.9% surge. Moreover, in 2026, the stock has risen by nearly 24.6%, also outpacing the SPX’s 8.7% gain.
